PATENT CLAIM ANALYSIS

Application Number: 16026658
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising deferasirox, a process for preparing such pharmaceutical composition, and its use in the treatment of chronic iron overload. The pharmaceutical composition comprises nanosized deferasirox having improved surface area and solubility. It also relates to a method for treatment of chronic iron overload which comprises administering a pharmaceutical composition comprising nanosized deferasirox.

Claim (Index 18):
The pharmaceutical composition of  claim 1 , wherein the nanomilled particles are prepared by a process comprising (1) homogenizing deferasirox and the at least one surface stabilizer to produce a homogenized dispersion of deferasirox; and (2) milling said homogenized dispersion to produce a slurry of deferasirox milled particles having an average particle size of less than or equal to about 2000 nm.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 95.0
- Lexical Diversity: 1.71053
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15185888', '10444066', '11568692', '11402264', '14198872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.737437754119653
- 35 USC 102 Novelty (BERT): 0.5023638868336237
- Combined Prediction Score: 0.71393036739105
- Mean Citation Score: 235.369036
- Max Citation Score: 248.36891
- Similarity Product: 167.51538203850623

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test